Literature DB >> 1728129

Colonic pH: a comparison between patients with colostomies due to trauma and colorectal cancer.

D Charalambides1, I Segal.   

Abstract

Colonic pH is important in the regulation of colonic cell growth, control of absorption and secretion, and bile acid degradation, which may be a key step in the development of colon cancer. This study determined the mucosal, luminal, and fecal pH in right and left colons of otherwise healthy patients who underwent colostomies because of trauma. The pH was evaluated while patients consumed a western diet. In addition, the mucosal, luminal, and fecal pH in patients with colostomies carried out for colorectal cancer also was assessed. All patients were blacks--a low-risk group for colorectal cancer. The results showed that mucosal pH was alkaline (pH 8) and was similar on both sides of the colon of healthy colostomates and in colon cancer patients. Luminal pH (7.6) was the same in healthy right colostomates and cancer patients and was significantly lower that mucosal pH. Fecal pH was significantly lower in right colostomates (6.0) than in left (6.5), and in healthy right colostomates compared with colon cancer patients (6.6). In addition, fecal pH was significantly lower than mucosal and luminal pH.

Entities:  

Mesh:

Year:  1992        PMID: 1728129

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

Review 1.  Pectin matrix as oral drug delivery vehicle for colon cancer treatment.

Authors:  Tin Wui Wong; Gaia Colombo; Fabio Sonvico
Journal:  AAPS PharmSciTech       Date:  2010-12-31       Impact factor: 3.246

2.  Lactate and pH in faeces from patients with colonic adenomas or cancer.

Authors:  H Hove; M Rye Clausen; P Brøbech Mortensen
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

3.  Pharmaceutical Development of 5-Fluorouracil-Eluting Stents for the Potential Treatment of Gastrointestinal Cancers and Related Obstructions.

Authors:  Mohammad Arafat; Yunmei Song; Kyle Brewer; Paris Fouladian; Ankit Parikh; Hugo Albrecht; Anton Blencowe; Sanjay Garg
Journal:  Drug Des Devel Ther       Date:  2021-04-09       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.